Ftse Mib
35.139,63
0,98%
DAX
20.271,33
0,67%
S&P 500
5.818,81
-0,30%
NASDAQ
18.968,11
-0,63%
Bitcoin
96.094,07
1,68%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vallon Pharmaceuticals Inc (VLON) Vallon Pharmaceuticals Inc (VLON) Notizie

Vallon Pharmaceuticals Inc

VLON
0,40
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/9/202422:36EDGAR2Form 8-K/A - Current report: [Amend]
06/9/202422:15EDGAR2Form 8-K - Current report
28/8/202423:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202423:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/8/202423:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
23/8/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/8/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/8/202422:05EDGAR2Form 8-K - Current report
16/8/202414:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/8/202414:07EDGAR2Form 8-K - Current report
02/8/202423:21EDGAR2Form ARS - Annual Report to Security Holders
02/8/202423:19EDGAR2Form DEF 14A - Other definitive proxy statements
26/7/202422:07EDGAR2Form 8-K - Current report
26/7/202422:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/7/202422:09EDGAR2Form PRE 14A - Other preliminary proxy statements
19/7/202422:03EDGAR2Form 8-K - Current report
19/7/202422:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/7/202415:07EDGAR2Form 8-K - Current report
27/6/202422:05EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/6/202414:05EDGAR2Form 8-K - Current report
26/6/202422:03EDGAR2Form S-1/A - General form for registration of securities..
18/6/202422:54EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/6/202422:48EDGAR2Form 8-K - Current report
14/6/202414:08EDGAR2Form 8-K - Current report
07/6/202422:06EDGAR2Form 8-K - Current report
31/5/202421:34EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/5/202421:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
22/5/202422:45EDGAR2Form 8-K - Current report
20/5/202422:13EDGAR2Form 8-K - Current report
20/5/202422:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/5/202422:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202422:44EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/5/202414:02EDGAR2Form 8-K - Current report
10/5/202423:24EDGAR2Form S-3 - Registration statement under Securities Act of..
10/5/202422:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:31EDGAR2Form DEF 14A - Other definitive proxy statements
01/4/202415:13EDGAR2Form 8-K - Current report
28/3/202421:45EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/3/202421:42EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:25EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/2/202422:23EDGAR2Form 8-K - Current report
02/2/202422:21EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
30/1/202414:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202414:12EDGAR2Form 8-K - Current report
19/1/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/1/202422:15EDGAR2Form 8-K - Current report
16/1/202414:45EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,40

La tua Cronologia

NASDAQ
VLON
Vallon Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network